Mico1,
Yes we do know something for sure. Ken Griffen admitted to spoofing and DCVax-L works. We also know there is a wait until MAA approval. We also know that based on regulator intervention that reduced trial powering by keeping 17 SOC/placebo patients out, Fraunhofer stating that this trial was enrolled only to the point statistically necessary and JAMA Oncology providing peer review of claims and methods that this MAA will be approved. This because unless there is regulatory approval, NWBO would have reason to legally claim regulator intervention hurt their chances at approval which won’t happen because regulators clearly have created a pathway forward for approval through acceptance of the SAP for this Phase 3 trial and approval of the PIP based on it. We also know that submissions for vaccines have been approved at a greater than 95% rate recently. I’d say we know quite a bit for sure and that is something some folks don’t want to remind us of while we wait. Best wishes.
News 
Market Data 
Discover 
